DSG, Omnicare, ClearTrial
Briefs for July 5th.
October 29, 2009
The contract research organization (CRO) PPD unleashed enough news for a year this week. The company announced a long list of new directions, ominous numbers and strategic shifts, including: • The company's quarterly earnings (not great, but not terrible); • The planned acquisition of the Chinese CRO Excel PharmaStudies, which will make PPD a major player in China; • The intent to spin off its compound-partnering business into a separate publicly traded company in early 2010; • The investment of $100 million ($30 million now, the rest later) in Celtic Therapeutics, an investment fund that focuses on therapeutic product candidates. • A new contract with the FDA to evaluate the agency's Center for Drug Evaluation and Research (CDER) post-market spontaneous adverse event surveillance system. Wow. PPD's executive chairman Fred Eshelman told Wall Street it's all part of a plan with “so many details and moving parts” to establish the company as…more...
August 03, 2009
There is lots of buzz about China being the next hot place for global clinical trials. The numbers being bandied about suggest $2 billion in Chinese pharmaceutical research and development in…more...
July 20, 2009
There are more active, commercial investigational new drug applications (INDs) circulating through the FDA than ever. Exactly 5,700 at the end of 2008. That's a record high—up 20 percent over the…more...
October 17, 2007
ClinPhone, a leading clinical technology suite, has been granted a Best Technological Development in Clinical Trial Management Systems Award for its drug accountability solution at the inaugural GCPj Awards 2007. The Good Clinical Practice Journal Awards were developed to recognize corporate and individual excellence and celebrate innovation. Bill Byrom, vice president, product management, said: “ClinPhone’s drug accountability…more...
October 15, 2007
CDISC annointed Omnicare Clinical Research registered Registered Solutions Provider status. Said the company’s Mark Penniston, global VP of Biometrics: â€œSince our first CDISC conformant submission in early 2004, Omnicare Clinical Research has had a rich history of successful data conversions. We recognize the importance of CDISC standards and have invested in providing on-line, up-to-date training for all…more...
October 12, 2007
In Nevada, a jury ordered Wyeth to pay $135 million to three women who took Premarin and Prempro. The jury said Wyeth acted with malice or fraud. Wyeth has no reserve fund for its hormone replacement therapy (HRT) cases, possibly because it has spent tens of billions of dollars to settle fen-phen litigation. The jury apparently was…more...
September 28, 2007
Covance expanded its facilities in Singapore for food manufacturers in the region. Manufacturers operating in Asia to export food to the U.S. will soon be able to send samples to a laboratory in Singapore. Chinese state media stated that the Singapore lab will initially focus on the testing of infant formula for release, stability and labeling data,…more...
Briefs for July 5th.
A leading technology supplier talks about China.
A real-world story of an e-diary study in the U.S. and Eastern Europe.
In addition to going public in London this year, the company has recently opened new offices in California and North Carolina, expanded its Chicago operation, and relocated its main U.S. office, in New Jersey, to larger premises.
“The ectasia registry is a giant step forward in addressing one of the most challenging complications of LASIK that we face today,” said Dr. Doyle Stulting, Emory University.
$150 million to be spent
Info & Opinion
© 2019 ClinPage. All Rights Reserved.